9:30am-2pm:(In PH Building, Floor C1)
2:30-4pm:(in NYP, M-107)

9:30 - 10:30am: Diabetes Management in Resource-Poor Settings
Jason Baker, MD

Diabetes Mellitus is a global epidemic, particularly in the developing world where a paucity of resources makes managing this disease extremely difficult. In this lecture, we’ll offer a Diabetes overview from a global perspective, focusing on the epidemiology, diagnosis and treatment of the following major categories of diabetes: Type 2, Type 1, Gestational, Malnutrition, Public health implications, Future directions in patient care and research.

Lecture Objectives:
· Review differences in diabetes clinical presentation between the developed and developing worlds
· Review differences in diabetes diagnosis between the developed and developing worlds
· Review differences in diabetes pathophysiology between the developed and developing worlds
· Review differences in diabetes management between the developed and developing worlds

---

10:30am - 11:45am: Optimizing Cardiovascular Clinical Skills for Resource-Poor Environments
Rajesh Vedanthan, MD

Mount Sinai Medical Center Through this lecture, students will appreciate the importance of the physical exam in resource-poor environments, appreciate the utility of simple diagnostic tests (e.g. CXR, ECG) in resource-poor environments, recognize the importance of a ultrasound (specifically echocardiography) as a diagnostic modality in resource-poor environments, understand the limitations of various diagnostic approaches, correlate clinical findings with known local epidemiology of disease

---

---

1:00 – 2:00pm Treating Hypertension in Resource-Poor Settings
Byron Demopoulos, MD

In this lecture, we will review the JNC 7 Guidelines and contrast literature from the international community. This review includes a discussion of the major outcomes trials that shaped the current guidelines. We’ll also discuss the goals of treating hypertension of different severities and the yield (NNTs) of such treatment as it pertains to resource poor environments where other health matters are often more pressing. This culminates in comparisons of the NNT’s associated with other cardio- and cerebro- vascular risk reducing strategies such as smoking cessation, exercise and management of diabetes and lipid disorders. This discussion focuses on cost economy models and ways of individualizing treatment of HTN and other cardio-vascular risk factors.

Lecture Objectives:
· Outline current hypertension treatment guidelines and list the major studies that influenced the current guidelines
· Critique current guidelines and list the limitations of the major outcomes trials upon which it is based
· Summarize the different pathophysiologic states that contribute to hypertension, including the role of salt, diet, exercise and BMI
· Compare the NNTs of hypertension treatment to other cardiovascular risk reducing treatments
· Generate lists of benefits, and relative cost-economy and international accessibility of major anti-hypertensive classes, in order to facilitate individualizing a patient’s hypertensive treatment.

---

2:30 – 4:00pm Lab: Splinting
Leah Hamburg, MD